Galena Biopharma (GALE), NCI to Collaborate on NeuVax Phase 2 in DCIS
Tweet Send to a Friend
Galena Biopharma (NASDAQ: GALE) announced a collaboration with the National Cancer Institute (NCI) to initiate a new, Phase 2 clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
